⌕
Immunome · IMNM · Nasdaq
Tenet 49 · Mixed
Compare
$17.18−2.44%At closeTenet 49 · Mixed
$17.18−0.43 (−2.44%)
At close: Nov 17, 2026, 4:00 PM ET· Nasdaq · USD

Immunome (IMNM) Institutional Ownership

Is the smart money (institutions and insiders) accumulating or distributing? One lagging input, not a buy signal.

Sources Ownership filingsQuarter ended How we compute thisNot investment advice

1 figure withheld by our checks. Each blank figure names its reason.

13F fund flowQuarter ended Sep 30, 2026: more funds added or entered than trimmed or exited, mild accumulation (9 new · 21 increased · 19 reduced · 3 closed · 13 unchanged or with no prior quarter on file). Flows at this scale move slowly; treat as context. These positions are 49 days old; the 45-day figure often quoted is the SEC filing deadline after quarter-end, not the age of the data. The counts above compare each filer’s position with its own previous 13F. The change in the number of filers and in the ownership share is not shown: the filings we read hold only each filer’s latest 13F, so there is no earlier quarter of the same filers to compare against. That is a limit of the source, not a statement about this company.
SHARES HELD BY 13F FILERS
withheld
withheld by our checks · 65 filers, Sep 30, 2026
# 13F FUNDS
65
13F VALUE
$151.9M
7.1M shares
Not reported in the company's filings for this period.
routine sells are usually compensation mechanics; open-market buys are the rarer signal. Rows labelled with another security are the derivative leg of a vest or exercise, not share sales
DateNameRoleTypeSharesPriceSEC filing
Sep 11, 2026Higgins JackChief Scientific OfficerAcquired · Option exercise18,000$1.35↗
Sep 11, 2026Higgins JackChief Scientific OfficerDisposed · Open-market sale13,200$25.32↗
Sep 11, 2026Higgins JackChief Scientific OfficerDisposed · Gift8,800—↗
Sep 11, 2026Higgins JackChief Scientific OfficerAcquired · Option exercise18,000Employee Stock Option (right to buy)—↗
Aug 12, 2026Barchas IsaacdirectorDisposed · Open-market sale11,048$27.25↗
Aug 11, 2026Barchas IsaacdirectorDisposed · Open-market sale62,291$26.23↗
Aug 10, 2026Barchas IsaacdirectorDisposed · Open-market sale10,125$26.07↗
Aug 7, 2026Barchas IsaacdirectorDisposed · Open-market sale15,248$26.06↗
Aug 6, 2026Barchas IsaacdirectorDisposed · Open-market sale20,840$26.06↗
Aug 4, 2026Horn KinneyCHIEF BUSINESS OFFICERAcquired · Option exercise50,366$12.92↗
Aug 4, 2026Horn KinneyCHIEF BUSINESS OFFICERAcquired · Option exercise40,250$10.60↗
Aug 4, 2026Horn KinneyCHIEF BUSINESS OFFICERDisposed · Open-market sale90,616$25.09↗
Aug 4, 2026Horn KinneyCHIEF BUSINESS OFFICERDisposed · Option exercise50,366Employee Stock Option (right to buy)—↗
Aug 4, 2026Horn KinneyCHIEF BUSINESS OFFICERDisposed · Option exercise40,250Employee Stock Option (right to buy)—↗
Jul 23, 2026Tsai PhilipChief Technical OfficerAcquired · Grant / award38,250—↗
Jul 23, 2026Tsai PhilipChief Technical OfficerAcquired · Grant / award76,500Employee Stock Option (right to buy)—↗
Jul 23, 2026Lechleider RobertChief Medical OfficerAcquired · Grant / award54,000—↗
Jul 23, 2026Lechleider RobertChief Medical OfficerAcquired · Grant / award108,000Employee Stock Option (right to buy)—↗
Jul 23, 2026Rosett MaxChief Financial OfficerAcquired · Grant / award47,250—↗
Jul 23, 2026Rosett MaxChief Financial OfficerAcquired · Grant / award94,500Employee Stock Option (right to buy)—↗

* Holdings as reported for Sep 30, 2026, 49 days old; funds file up to 45 days after each quarter-end, so the newest complete quarter runs 45 to 135 days behind.

** A price of “—” marks an option exercise, RSU vest or a filing without a usable per-share price, not a $0 trade.

How many 13F filers hold Immunome?

Immunome was held by 65 13F filers as of Sep 30, 2026.

Not investment advice.

Install Tenet on your phone

Tenet home pageMethodology© 2026 Tenet Investing Inc.

Data from Intrinio and Financial Modeling Prep.